July 31, 2019 04:18 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 540 in its research report dated July 30, 2019.
May 09, 2019 04:56 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 560 in its research report dated May 09, 2019.
January 25, 2019 04:07 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 620 in its research report dated January 23, 2019.
October 24, 2018 03:59 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 560 in its research report dated October 23, 2018.
July 31, 2018 04:11 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 525 in its research report dated July 30, 2018.
May 24, 2018 05:52 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 460 in its research report dated May 17, 2018.
November 15, 2017 05:12 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 530 in its research report dated November 09, 2017.
July 25, 2017 05:35 PM IST KR Choksey recommended hold rating on Alembic Pharma with a target price of Rs 580 in its research report dated July 21, 2017.
July 25, 2017 03:32 PM IST ICICI Direct has recommended hold rating on Alembic Pharma with a target price of Rs 570 in its research report dated July 21, 2017.
July 24, 2017 01:31 PM IST HDFC Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 635 in its research report dated July 20, 2017.
May 10, 2017 04:24 PM IST Axis Direct recommended hold rating on Alembic Pharmaceuticals with a target price of Rs 610 in its research report dated May 09, 2017.
January 30, 2017 03:28 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 615 in its research report dated January 30, 2017.
January 30, 2017 01:31 PM IST KR Choksey has recommended accumulate rating on Alembic Pharma with a target price of Rs 667 in its research report dated January 27, 2017.
November 04, 2016 05:54 PM IST GEPL Capital is bullish on Alembic Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 808 in its research report dated October 19, 2016.
November 01, 2016 05:25 PM IST Axis Direct recommended hold rating on Alembic Pharmaceuticals with a target price of Rs 700 in its research report dated October 26, 2016.
October 05, 2016 07:01 PM IST Anand Rathi is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 728 in its research report dated September 30, 2016.
August 02, 2016 04:49 PM IST ICICI Direct has recommended hold rating on Alembic Pharma with a target price of Rs 620 in its research report dated August 02, 2016.
August 02, 2016 01:56 PM IST Axis Direct has recommended hold rating on Alembic Pharma with a target price of Rs 600 in its research report dated August 01, 2016.
August 01, 2016 03:47 PM IST KR Choksey recommended hold rating on Alembic Pharma with a target price of Rs 640 in its research report dated August 01, 2016.
July 07, 2016 02:09 PM IST Axis Direct recommended hold rating on Alembic Pharma with a target price of Rs 600 in its research report dated July 05, 2016.
July 01, 2016 03:54 PM IST Anand Rathi recommended hold rating on Alembic Pharma with a target price of Rs 576 in its research report dated June 30, 2016.
April 29, 2016 05:44 PM IST Axis Securities is bearish on Alembic Pharma has recommended reduce rating on the stock with a target price of Rs 560 in its research report dated April 28, 2016.
April 29, 2016 10:31 AM IST KRChoksey has recommended hold rating on Alembic Pharma with a target price of Rs 623 in its research report dated April 28, 2016.
January 27, 2016 11:42 AM IST ICICIDirect is bullish on Alembic Pharma and has recommended buy rating on the stock with a target price of Rs 790 in its research report dated January 21, 2016.
January 25, 2016 05:34 PM IST Axis Securities is bearish on Alembic Pharma and has recommended sell rating on the stock with a target price of Rs 560 in its research report dated January 22, 2016.
